Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02640209
Brief Title: Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)

First Submitted : December 22, 2015
First Submitted that Met QC Criteria : December 22, 2015
First Posted : December 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 5, 2020
Last Update Posted : May 7, 2020